Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward Eid

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Skinmed|December 20, 2022
Prevalence of Cosmetic Procedures among Lebanese WomenCharbel Elias, Nour Younis, Joelle Allam, et al.
Scientific Reports|August 6, 2025
Natural history study of recessive dystrophic epidermolysis bullosa wounds and patient reported outcomes using mobile application home photographyShivali Fulchand, Jaron Nazaroff, Nicki Harris, et al.
Clinical Genetics|May 1, 2020
A novel TRAF3IP2 variant causing familial scarring alopecia with mixed features of discoid lupus erythematosus and folliculitis decalvansGeorges Nemer, Nehme El-Hachem, Edward Eid, et al.
Journal of the American Academy of Dermatology|May 12, 2024
Functional genotype-phenotype associations in recessive dystrophic epidermolysis bullosaJodi Y So, Jaron Nazaroff, Vamsi K Yenamandra, et al.
Iscience|October 26, 2020
Integrative Transcriptome Analyses Empower the Anti-COVID-19 Drug ArsenalNehme El-Hachem, Edward Eid, Georges Nemer, et al.
Clinical and Experimental Pharmacology & Physiology|June 20, 2020
SuPAR, a potential inflammatory mediator in psoriasis pathogenesisLamiaa Hamie, Edward Eid, Ossama Abbas, et al.
JAMA Dermatology|October 15, 2025
Development and Validation of a Scale to Assess Epidermolysis Bullosa Simplex SeverityAustin N Johnson, Pirunthan Pathmarajah, Edward Eid, et al.
Lancet (London, England)|June 26, 2025
Prademagene zamikeracel for recessive dystrophic epidermolysis bullosa wounds (VIITAL): a two-centre, randomised, open-label, intrapatient-controlled phase 3 trialJean Y Tang, M Peter Marinkovich, Karen Wiss, et al.
The British Journal of Dermatology|January 10, 2025
Functional genotype classification groups distinguish disease severity in recessive dystrophic epidermolysis bullosaPirunthan Pathmarajah, Edward Eid, Jaron Nazaroff, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Skinmed|December 20, 2022
Prevalence of Cosmetic Procedures among Lebanese WomenCharbel Elias, Nour Younis, Joelle Allam, et al.
Scientific Reports|August 6, 2025
Natural history study of recessive dystrophic epidermolysis bullosa wounds and patient reported outcomes using mobile application home photographyShivali Fulchand, Jaron Nazaroff, Nicki Harris, et al.
Clinical Genetics|May 1, 2020
A novel TRAF3IP2 variant causing familial scarring alopecia with mixed features of discoid lupus erythematosus and folliculitis decalvansGeorges Nemer, Nehme El-Hachem, Edward Eid, et al.
Journal of the American Academy of Dermatology|May 12, 2024
Functional genotype-phenotype associations in recessive dystrophic epidermolysis bullosaJodi Y So, Jaron Nazaroff, Vamsi K Yenamandra, et al.
Iscience|October 26, 2020
Integrative Transcriptome Analyses Empower the Anti-COVID-19 Drug ArsenalNehme El-Hachem, Edward Eid, Georges Nemer, et al.
Clinical and Experimental Pharmacology & Physiology|June 20, 2020
SuPAR, a potential inflammatory mediator in psoriasis pathogenesisLamiaa Hamie, Edward Eid, Ossama Abbas, et al.
JAMA Dermatology|October 15, 2025
Development and Validation of a Scale to Assess Epidermolysis Bullosa Simplex SeverityAustin N Johnson, Pirunthan Pathmarajah, Edward Eid, et al.
Lancet (London, England)|June 26, 2025
Prademagene zamikeracel for recessive dystrophic epidermolysis bullosa wounds (VIITAL): a two-centre, randomised, open-label, intrapatient-controlled phase 3 trialJean Y Tang, M Peter Marinkovich, Karen Wiss, et al.
The British Journal of Dermatology|January 10, 2025
Functional genotype classification groups distinguish disease severity in recessive dystrophic epidermolysis bullosaPirunthan Pathmarajah, Edward Eid, Jaron Nazaroff, et al.
Pageof 3